Combination of the vascular disrupting agent DMXAA (AS1404) with bevacizumab and paclitaxel produces synergistic antitumor activity in lung cancer xenografts
Year: 2007
Type: article
Source: Cancer Research
Authors: Hakim Djeha, Kirti Shah, Grainne McGeever, Donna Dobinson, Colin Green
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2575189539
